Q1 2022 Holdings
Filed 2022-05-16 | 373 holdings | $14.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $139.0K | 6,346 | 1.0% |
| Atea Pharmaceuticals Inc(AVIR) | COM | 04683R106 | $140.0K | 19,333 | 1.0% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $141.0K | 4,131 | 1.0% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $146.0K | 19,452 | 1.0% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $154.0K | 4,176 | 1.1% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $158.0K | 2,348 | 1.1% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $200.0K | 10,359 | 1.4% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $209.0K | 5,053 | 1.5% |
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $229.0K | 1,344 | 1.6% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $252.0K | 1,336 | 1.8% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $256.0K | 20,653 | 1.8% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $319.0K | 2,722 | 2.3% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $327.0K | 2,003 | 2.3% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $336.0K | 11,541 | 2.4% |
| Biogen Inc(BIIB) | COM | 09062X103 | $339.0K | 1,612 | 2.4% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $346.0K | 4,486 | 2.5% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $392.0K | 16,172 | 2.8% |
| Crescent Cap BDC Inc(CCAP) | COM | 225655109 | $460.0K | 25,831 | 3.3% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $529.0K | 32,542 | 3.7% |
| Cubesmart(CUBE) | COM | 229663109 | $1.5M | 28,337 | 10.4% |
| Crown Castle Intl Corp New(CCI) | COM | 22822V101 | $1.5M | 8,023 | 10.5% |
| Cousins Pptys Inc(CUZ) | COM NEW | 222795502 | $1.6M | 40,641 | 11.6% |
| Barrick Gold Corp(ABX) | COM | 067901108 | $2.1M | 86,301 | 15.0% |